A carregar...
Which are the antibodies to watch in 2013?
The start of the new year signals that it is time for mAbs’ annual review of the therapeutic monoclonal antibodies (mAbs) in active Phase 2/3 or Phase 3 clinical studies. The entire clinical pipeline currently includes ~350 mAbs, but most of these are in early development. As of the beginning of 201...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Landes Bioscience
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3564874/ https://ncbi.nlm.nih.gov/pubmed/23254906 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.22976 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|